Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls

Barclays initiated coverage of Hinge Health (HNGE) with an Overweight rating and $43 price target. Musculoskeletal issues are expensive, and Hinge can “bend the cost curve” with digital physical therapy, the firm says. KeyBanc, Morgan Stanley, RBC Capital, Stifel, Truist, Evercore ISI, William Blair, Hinge Health, BofA, Canaccord, and Piper Sandler started coverage of the stock with Buy-equivalent ratings.